Auxly Cannabis Group Inc
TSX:XLY

Watchlist Manager
Auxly Cannabis Group Inc Logo
Auxly Cannabis Group Inc
TSX:XLY
Watchlist
Price: 0.155 CAD 3.33% Market Closed
Market Cap: 209m CAD

Auxly Cannabis Group Inc
Investor Relations

Auxly Cannabis Group, Inc. engages in developing, manufacturing, and distributing branded cannabis products for wellness and recreational consumers. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-08-20. The firm is focused on developing, manufacturing and distributing branded cannabis products for wellness and recreational consumers. The firm's segments include Canadian cannabis operations and South American cannabis operations. Both segments are engaged in the cultivation and sale of cannabis products in respective regions. The company provides various products, including vaporizers, edibles, pre-rolls, capsules and oils and concentrates. The firm's brands include Back Forty, Foray, Dosecann and Kolab Project. The company is also a licensed producer of Cannabis 2.0 as well as Cannabis 1.0 products. The firm's subsidiaries include Dosecann LD Inc., Kolab Project Inc., Robinson's Cannabis Inc., Robinson's Outdoor Grow Inc. and Inverell S.A.

Show more
Loading
XLY
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2023
Call Date
May 15, 2023
AI Summary
Q1 2023

Revenue Growth: Net revenues were CAD24 million, up 6% year-over-year but down 3% from Q4 2022, showing resilience against typical Q1 seasonality.

Profitability Milestone: Auxly achieved positive adjusted EBITDA for the first time in its history, driven by higher revenues, lower cost of goods, and reduced SG&A.

Margin Improvement: Gross profit margin reached 33%, double last year's Q1, and the margin on finished cannabis inventory sold improved to 37%.

SG&A Reduction: Selling, general and administrative expenses dropped to CAD10.1 million, down from CAD12.6 million a year earlier.

Cash Flow Turnaround: Operating cash flow swung from a CAD7 million use last year to a CAD3.2 million source in Q1 2023.

Product Focus: The company continued to shift its focus to dried flower, pre-rolls, and vapes, now representing 55% of sales, up from 39% a year ago.

Operational Efficiency: Investments in automation and new pre-roll machinery are expected to boost throughput and support further market share gains.

Key Financials
Net Revenue
CAD24 million
Gross Profit Margin
33%
Margin on Finished Cannabis Inventory Sold
37%
SG&A
CAD10.1 million
Adjusted EBITDA
Positive
Net Loss
CAD10.2 million
Operating Cash Flow
CAD3.2 million (inflow)
Market Share
5.5%
Share of Sales in Dried Flower, Pre-rolls and Vapes
55%
Earnings Call Recording
Other Earnings Calls

Management

Mr. Hugo M. Alves
CEO & Director
No Bio Available
Mr. Michael David Lickver
President
No Bio Available
Mr. Travis Wong
Chief Financial Officer
No Bio Available
Mr. Ron Fichter
General Counsel & Corporate Secretary
No Bio Available
Mr. Andrew MacMillan
Senior Vice President of Commercial
No Bio Available
Mr. Kevin Furet
Chief Cultivation & Genetics Officer
No Bio Available
Mr. Vladimir Klacar
Senior Vice President of Regulatory Affairs & Planning
No Bio Available

Contacts

Address
ONTARIO
TORONTO
777 Richmond St. W, Unit 002
Contacts
+16478120121.0
www.auxly.com